Omalizumab Therapy for Allergic Bronchopulmonary Aspergillosis in Children with Cystic Fibrosis: A Synthesis of Published Evidence

被引：50
|
作者：
Tanou, Kalliopi [1 ,2 ]
Zintzaras, Elias [3 ,4 ]
Kaditis, Athanasios G. [1 ,2 ]
机构：
[1] Univ Athens, Sch Med, Dept Pediat 1, Pediat Pulmonol Unit, GR-11527 Athens, Greece
[2] Aghia Sophia Childrens Hosp, Athens, Greece
[3] Tufts Univ, Sch Med, Tufts Med Ctr, Ctr Clin Evidence Synth,Inst Clin Res & Hlth Poli, Boston, MA 02111 USA
[4] Univ Thessaly, Sch Med, Dept Biomath, Larisa, Greece
来源：
PEDIATRIC PULMONOLOGY | 2014年 / 49卷 / 05期
关键词：
ABPA; A; fumigatus; anti-IgE; ANTI-IGE ANTIBODY; ABPA; CF;
D O I：
10.1002/ppul.22937
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
Allergic bronchopulmonary aspergillosis (ABPA) complicating cystic fibrosis (CF) is treated with corticosteroids. Since elevated IgE is a cardinal abnormality, anti-IgE has been used sporadically as adjuvant treatment. In eight case reports, 13 children with CF and ABPA received anti-IgE resulting in improved FEV1, fewer respiratory symptoms and decreased corticosteroid use. Pediatr Pulmonol. 2014; 49:503-507. (c) 2013 Wiley Periodicals, Inc.
引用
收藏
页码：503 / 507
页数：5
相关论文
共 50 条
  • [1] OMALIZUMAB FOR ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS IN ADULTS WITH CYSTIC FIBROSIS
    Koutsokera, A.
    Corriveau, S.
    Sykes, J.
    Vadas, P.
    Chaparro, C.
    McIntyre, K.
    Tullis, E.
    Stephenson, A.
    PEDIATRIC PULMONOLOGY, 2018, 53 : 328 - 328
  • [2] OMALIZUMAB IN ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS IN PATIENTS WITH CYSTIC FIBROSIS
    Ashkenazi, M.
    Sity, S.
    De Boeck, C.
    Efrati, O.
    PEDIATRIC PULMONOLOGY, 2016, 51 : 278 - 278
  • [3] Omalizumab Treatment for Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis
    Emiralioglu, Nagehan
    Dogru, Deniz
    Tugcu, Gokcen Dilsa
    Yalcin, Ebru
    Kiper, Nural
    Ozcelik, Ugur
    ANNALS OF PHARMACOTHERAPY, 2016, 50 (03) : 188 - 193
  • [4] Omalizumab in allergic bronchopulmonary aspergillosis in patients with cystic fibrosis
    Ashkenazi, Moshe
    Sity, Saray
    Sarouk, Ifat
    El Bar Aluma, Bat
    Dagan, Adi
    Bezalel, Yael
    Bentur, Lea
    De Boeck, Kris
    Efrati, Ori
    JOURNAL OF ASTHMA AND ALLERGY, 2018, 11 : 101 - 107
  • [5] Omalizumab for asthma and allergic bronchopulmonary aspergillosis in adults with cystic fibrosis
    Koutsokera, Angela
    Corriveau, Sophie
    Sykes, Jenna
    Coriati, Adele
    Cortes, Daniel
    Vadas, Peter
    Chaparro, Cecilia
    McIntyre, Kieran
    Tullis, Elizabeth
    Stephenson, Anne L.
    JOURNAL OF CYSTIC FIBROSIS, 2020, 19 (01) : 119 - 124
  • [6] Cystic Fibrosis: Does Omalizumab work in allergic Bronchopulmonary Aspergillosis?
    Simon, Annika
    PNEUMOLOGIE, 2018, 72 (03): : 184 - 184
  • [7] Omalizumab for the treatment of allergic bronchopulmonary aspergillosis (ABPA) in children "th cystic fibrosis (CF)
    Gartner, Silvia
    Rovira, Sandra
    de Mir, Ines
    Torrent, Alba
    Caurin, Belen
    Sacoto, Gabriela
    Canino, Elisa
    Moreno-Galdo, Antonio
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [8] Role of omalizumab in the management of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis
    Delgado Pecellin, Isabel
    Quintana Gallego, Esther
    Pedregal Solano, Celeste
    Calero Acuna, Carmen
    MEDICINA CLINICA, 2015, 144 (04): : 190 - 191
  • [9] OMALIZUMAB FOR THE TREATMENT OF ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS IN PEDIATRIC PATIENTS WITH CYSTIC FIBROSIS
    Trogen, B.
    Parikh, P.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S101 - S101
  • [10] Omalizumab treatment for allergic bronchopulmonary aspergillosis in young patients with cystic fibrosis
    Perisson, Caroline
    Destruys, Leila
    Grenet, Dominique
    Bassinet, Laurence
    Derelle, Jocelyne
    Sermet-Gaudelus, Isabelle
    Thumerelle, Caroline
    Prevotat, Anne
    Rosner, Vincent
    Clement, Annick
    Corvol, Harriet
    RESPIRATORY MEDICINE, 2017, 133 : 12 - 15
12345